[HTML][HTML] Hormone receptor status, tumor characteristics, and prognosis: a prospective cohort of breast cancer patients
LK Dunnwald, MA Rossing, CI Li - Breast cancer research, 2007 - Springer
Background Breast cancer patients with tumors that are estrogen receptor (ER)-positive and/or
progesterone receptor (PR)-positive have lower risks of mortality after their diagnosis …
progesterone receptor (PR)-positive have lower risks of mortality after their diagnosis …
[PDF][PDF] Quantitative fluoroestradiol positron emission tomography imaging predicts response to endocrine treatment in breast cancer
…, PH Petra, LM Peterson, EK Schubert, LK Dunnwald… - J Clin Oncol, 2006 - academia.edu
Purpose In breast cancer,[18F] fluoroestradiol (FES) positron emission tomography (PET)
correlates with estrogen receptors (ER) expression and predicts response to tamoxifen. We …
correlates with estrogen receptors (ER) expression and predicts response to tamoxifen. We …
Blood flow and metabolism in locally advanced breast cancer: relationship to response to therapy
DA Mankoff, LK Dunnwald, JR Gralow… - Journal of Nuclear …, 2002 - Soc Nuclear Med
Locally advanced breast cancer (LABC) is commonly treated with neoadjuvant chemotherapy
followed by definitive surgery. The factors influencing the response of LABC to presurgical …
followed by definitive surgery. The factors influencing the response of LABC to presurgical …
Increased false negative sentinel node biopsy rates after preoperative chemotherapy for invasive breast carcinoma
…, BO Anderson, DR Byrd, LK Dunnwald… - … Journal of the …, 2000 - Wiley Online Library
BACKGROUND Sentinel lymph node dissection (SLND) has been a promising new
technique in breast carcinoma staging, but could be unreliable in certain patient subsets. The …
technique in breast carcinoma staging, but could be unreliable in certain patient subsets. The …
Changes in blood flow and metabolism in locally advanced breast cancer treated with neoadjuvant chemotherapy
DA Mankoff, LK Dunnwald, JR Gralow… - Journal of Nuclear …, 2003 - Soc Nuclear Med
Locally advanced breast cancer (LABC) is commonly treated with neoadjuvant chemotherapy
followed by definitive surgery. The factors influencing the response of LABC to presurgical …
followed by definitive surgery. The factors influencing the response of LABC to presurgical …
[HTML][HTML] Tumor metabolism and blood flow changes by positron emission tomography: relation to survival in patients treated with neoadjuvant chemotherapy for locally …
LK Dunnwald, JR Gralow, GK Ellis… - Journal of Clinical …, 2008 - ncbi.nlm.nih.gov
Purpose Patients with locally advanced breast carcinoma (LABC) receive preoperative
chemotherapy to provide early systemic treatment and assess in vivo tumor response. Serial …
chemotherapy to provide early systemic treatment and assess in vivo tumor response. Serial …
SUV varies with time after injection in 18F-FDG PET of breast cancer: characterization and method to adjust for time differences
…, P Kinahan, J Tseng, LK Dunnwald… - Journal of Nuclear …, 2003 - Soc Nuclear Med
The purpose of this study was to measure how 18 F-FDG PET standardized uptake values (SUVs)
change over time in breast cancer and to examine the feasibility of a method to adjust …
change over time in breast cancer and to examine the feasibility of a method to adjust …
Use of serial FDG PET to measure the response of bone-dominant breast cancer to therapy
…, JR Gralow, EK Schubert, KJ Rinn, LK Dunnwald… - Academic radiology, 2002 - Elsevier
RATIONALE AND OBJECTIVES: The authors performed this study to determine the feasibility
of using quantitative 2-[fluorine-18]fluoro-2-deoxy-d-glucose (FDG) positron emission …
of using quantitative 2-[fluorine-18]fluoro-2-deoxy-d-glucose (FDG) positron emission …
18F-FDG kinetics in locally advanced breast cancer: correlation with tumor blood flow and changes in response to neoadjuvant chemotherapy
J Tseng, LK Dunnwald, EK Schubert… - Journal of Nuclear …, 2004 - Soc Nuclear Med
The aim of this study was to characterize the biologic response of locally advanced breast
cancer (LABC) to chemotherapy using 15 O-water–derived blood flow measurements and 18 F…
cancer (LABC) to chemotherapy using 15 O-water–derived blood flow measurements and 18 F…
PET tumor metabolism in locally advanced breast cancer patients undergoing neoadjuvant chemotherapy: value of static versus kinetic measures of …
LK Dunnwald, RK Doot, JM Specht, JR Gralow… - Clinical Cancer …, 2011 - AACR
Purpose: Changes in tumor metabolism from positron emission tomography (PET) in locally
advanced breast cancer (LABC) patients treated with neoadjuvant chemotherapy (NC) are …
advanced breast cancer (LABC) patients treated with neoadjuvant chemotherapy (NC) are …